CARLSBAD, Calif., May 15, 2024
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today
announced that management will conduct its 2024 virtual Annual
Meeting of Stockholders followed by a general corporate update on
Thursday, June 6, 2024.
The agenda for the event is as follows:
- 5:00 p.m. – 5:15 p.m. ET
(2:00 p.m. – 2:15 p.m. PT) – Virtual Annual Meeting of
Stockholders
- All stockholders of record at the close of business on
April 8, 2024, are invited to
participate in the virtual Annual Meeting webcast, which will be
broadcast live at
http://www.virtualshareholdermeeting.com/IONS2024.
- Stockholders of record will receive an official proxy card from
their brokerage firm. Each proxy card contains a 16-digit control
number required to log-in, vote and submit questions during the
webcast.
- Ionis does not provide proxy cards or have access to proxy card
information, including 16-digit control numbers. For help obtaining
a proxy card or to locate their control number or for instructions
to access the webcast, stockholders of record should contact their
brokerage firm before Thursday, May
23.
- A help line will be available on the registration page of the
live webcast for participants requiring technical assistance in
accessing or participating during the live event. There will not be
a replay of this session.
- 5:30 p.m. ET (2:30 p.m. PT) – Virtual corporate update
- Brett P. Monia, Ph.D., Ionis'
chief executive officer, will provide a general corporate update
followed by a question-and-answer session.
- All interested parties may access the webcast live
at https://event.webcasts.com/starthere.jsp?ei=1659973&tp_key=9ca016319a.
An archived replay of the webcast will be posted for a limited time
following the meeting at that same address.
- Questions for management may be submitted in advance of the
webcast and will be addressed during the question-and-answer
portion of the webcast. Please submit questions via email to
IonisAnnualMeeting@ionisph.com by Tuesday,
June 4. Questions not addressed during the webcast will be
answered by email following the meeting.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better
futures to people with serious diseases. Ionis currently has five
marketed medicines and a leading pipeline in neurology, cardiology,
and other areas of high patient need. As the pioneer in
RNA-targeted medicines, Ionis continues to drive innovation in RNA
therapies in addition to advancing new approaches in gene editing.
A deep understanding of disease biology and industry-leading
technology propels our work, coupled with a passion and urgency to
deliver life-changing advances for patients. To learn more about
Ionis, visit Ionispharma.com and follow us on X (Twitter) and
LinkedIn.
Ionis Pharmaceuticals Investor Contact:
D.
Wade Walke, Ph.D. –
info@ionisph.com – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer –
CorporateCommunications@ionisph.com – 760-603-4679
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-host-2024-virtual-annual-meeting-of-stockholders-302145477.html
SOURCE Ionis Pharmaceuticals, Inc.